Liposomal amphotericin b for empirical therapy in patients with persistent fever and neutropenia Academic Article uri icon

Overview

MeSH Major

  • Amphotericin B
  • Antifungal Agents
  • Fever
  • Mycoses
  • Neutropenia

abstract

  • Liposomal amphotericin B is as effective as conventional amphotericin B for empirical antifungal therapy in patients with fever and neutropenia, and it is associated with fewer breakthrough fungal infections, less infusion-related toxicity, and less nephrotoxicity.

publication date

  • March 11, 1999

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJM199903113401004

PubMed ID

  • 10072411

Additional Document Info

start page

  • 764

end page

  • 71

volume

  • 340

number

  • 10